Virulizin
information and resources from the National Cancer Institute
NCI Thesaurus | Virulizin
A natural biological response modifier (BRM) isolated from bovine reticuloendothelial tissue. Viruzlin may enhance cell-mediated immune response to tumor cells by direct macrophage activation. NCI Thesaurus | Virulizin
A natural biological response modifier (BRM) isolated from bovine reticuloendothelial tissue. Viruzlin may enhance cell-mediated immune response to tumor cells by direct macrophage activation.
|
|
|
|
news articles
Lorus Publishes studies on three distinct lines of research ... Mar 1, 2006
PR Newswire (press release), Exchange under the symbol LRP. Virulizin(R) is a registered trademark of Lorus Therapeutics Inc. Forward Looking Statements Except ...
Lorus announces that Elly Reisman has stepped down from the Board ... Dec 6, 2005
PR Newswire (press release), Exchange under the symbol LRP. Virulizin(R) is a registered trademark of Lorus Therapeutics Inc. Forward Looking Statements Except ...
Lorus announces international conference presentation of the ... Dec 12, 2005
PR Newswire (press release), American Stock Exchange under the symbol LRP. Virulizin is a registered trademark of Lorus Therapeutics Inc. About GTI-2040 GTI-2040 is ...
Lorus announces that Elly Reisman has stepped down from the Board ... Dec 6, 2005
Biotech Intelligence (press release), Exchange under the symbol LRP. Virulizin(R) is a registered trademark of Lorus Therapeutics Inc. Except for historical information ...
Lorus announces international conference presentation of the ... Dec 12, 2005
Yahoo! News (press release) Stock Exchange under the symbol LRP. Virulizin is a registered trademark of Lorus Therapeutics Inc. GTI-2040 is an antisense drug ...
|
|
